Overview Presentation Reports Financial Management Stock FAQ Alert Contact Stock Quote () () Presentations Investors Presentation - December 2017 Financial Reports 4th Quarter 2017 2nd Quarter 2017 Immediate Reports Juventas’s trial’s end-points for closing wounds on a diabetic foot not met 18/01/2018 CEO’s letter to shareholders – annual summary 08/01/2018 Memorandum of Understanding for investing $500,000 in Valens in exchange for allocation of about 6.25% of preferred shares 24/12/2017 Libental fully repaid loan worth NIS 7 million to Merchavia 04/12/2017 Read more Mail Alert Subscribe to Receive Notifications by Email: First Name Last Name Email Send
Memorandum of Understanding for investing $500,000 in Valens in exchange for allocation of about 6.25% of preferred shares 24/12/2017
